NAGA, alpha-N-acetylgalactosaminidase, 4668

N. diseases: 86; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0002986
Disease: Fabry Disease
Fabry Disease
0.130 Biomarker disease BEFREE Because this modified NAGA is hardly expected to cause an allergic reaction in Fabry disease patients, it is highly promising as a new and safe enzyme for ERT for Fabry disease. 19853240 2009
CUI: C0002986
Disease: Fabry Disease
Fabry Disease
0.130 Biomarker disease BEFREE Alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency (Schindler/Kanzaki disease) is a clinically and pathologically heterogeneous genetic disease with a wide spectrum including an early onset neuroaxonal dystrophy (Schindler disease) and late onset angiokeratoma corporis diffusum (Kanzaki disease). 14685826 2004
CUI: C0002986
Disease: Fabry Disease
Fabry Disease
0.130 GeneticVariation disease BEFREE The molecular lesion in the alpha-N-acetylgalactosaminidase gene that causes angiokeratoma corporis diffusum with glycopeptiduria. 8040340 1994
CUI: C0002986
Disease: Fabry Disease
Fabry Disease
0.130 Biomarker disease HPO